Following positive research findings , retatrutide, a new peptide treatment for treating non-insulin dependent hyperglycemia , has received regulatory approval from UK’s Drug and Healthcare Agency https://sachingdii135056.articlesblogger.com/63645496/retatrutide-treatment-peptide-british-green-light-and-access